BioNexus Gene Lab Corp.
$2.28
▼
-2.72%
2026-04-21 05:38:01
www.bionexusgenelab.com
NCM: BGLC
Explore BioNexus Gene Lab Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.32 M
Current Price
$2.28
52W High / Low
$15.6 / $1.92
Stock P/E
—
Book Value
$3.79
Dividend Yield
—
ROCE
-23.07%
ROE
-28.35%
Face Value
—
EPS
$-1.28
Exp Qtr EPS
—
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
30
Beta
2.31
Debt / Equity
3.43
Current Ratio
8.3
Quick Ratio
3.1
Forward P/E
—
Price / Sales
0.54
Enterprise Value
$1.26 M
EV / EBITDA
-0.54
EV / Revenue
0.13
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Sociedad Química y Minera de Chile S.A. | $86.83 | 42.17 | $23.26 B | 10.9% | 8.47% | 9.67% | $71,500 / $27,000 | $19.93 |
| 2. | J-Star Holding Co., Ltd. | $0.25 | 4.43 | $4.92 M | — | 7.94% | 4.97% | $6.45 / $0.26 | $0.82 |
| 3. | Axalta Coating Systems Ltd. | $29.68 | 16.79 | $6.35 B | — | 11.8% | 17.43% | $35.72 / $24.94 | $10.99 |
| 4. | Albemarle Corporation | $196.53 | — | $23.22 B | 0.83% | 0.46% | -4.66% | $215.71 / $50.85 | $62 |
| 5. | Northern Technologies International Corporation | $8.08 | — | $76.41 M | 0.49% | -7.58% | 0.36% | $10.03 / $6.75 | $7.63 |
| 6. | SenesTech, Inc. | $1.65 | — | $8.75 M | — | -54.01% | -1.06% | $6.24 / $1.54 | $1.83 |
| 7. | PPG Industries, Inc. | $111.9 | 16.18 | $25.09 B | 2.48% | 12.61% | 21.08% | $133.43 / $93.39 | $35.54 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 2.54 M | 2.26 M | 2.14 M | 2.52 M | 2.63 M |
| Operating Profit | -0.81 M | -0.7 M | -0.62 M | -0.8 M | -1.47 M |
| Net Profit | -0.71 M | -0.62 M | -0.62 M | -0.35 M | -1.35 M |
| EPS in Rs | -0.3 | -0.26 | -0.26 | -0.15 | -0.57 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 9.51 M | 9.77 M | 10.93 M | 13.36 M |
| Operating Profit | -1.96 M | -3.08 M | -0.29 M | 1.06 M |
| Net Profit | -1.6 M | -2.63 M | -0.36 M | 0.75 M |
| EPS in Rs | -0.68 | -1.11 | -0.15 | 0.32 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 10.43 M | 11.4 M | 8.74 M | 9.57 M |
| Total Liabilities | 2.11 M | 1.74 M | 2.08 M | 2.39 M |
| Equity | 8.32 M | 9.66 M | 6.67 M | 7.18 M |
| Current Assets | 7.43 M | 8.05 M | 6.02 M | 7.15 M |
| Current Liabilities | 1.95 M | 1.63 M | 2 M | 2.33 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -2.23 M | -1.82 M | 0.55 M | 0.01 M |
| Investing CF | 0.42 M | -1.79 M | -0.45 M | -0.49 M |
| Financing CF | 0.14 M | 6.27 M | 0.11 M | -0.03 M |
| Free CF | -2.46 M | -1.97 M | 0.5 M | 0.01 M |
| Capex | -0.23 M | -0.15 M | -0.05 M | -0 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -2.66% | -10.6% | -18.21% | — |
| Earnings Growth % | 39.2% | -638.57% | -147.36% | — |
| Profit Margin % | -16.81% | -26.91% | -3.26% | 5.62% |
| Operating Margin % | -20.57% | -31.52% | -2.66% | 7.9% |
| Gross Margin % | 13.56% | 13.61% | 11.52% | 16.96% |
| EBITDA Margin % | -14.94% | -25.43% | -1.7% | 8.71% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-04-07 | 1:0.1 |